Evidence map›Paper›PMID 37766819›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2023

In-vitro and ex-vivo antidiabetic, and antioxidant activities of Box-Behnken design optimized

Rama Tyagi, Ayesha Waheed, Neeraj Kumar, Mohd Mujeeb, Tanveer Naved, Mohammad Rashid Khan, Khaled Alhosaini, Yasser A Alqarni, Rani Rahat, Perwez Alam and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Bioadhesive hybrid system of niosomes and pH sensitiveSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Rama TyagiAmity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh 201301, India.
Ayesha WaheedDepartment of Pharmaceutics, SPER, Jamia Hamdard, New Delhi 110062, India.
Neeraj KumarDepartment of Pharmaceutics, SPER, Jamia Hamdard, New Delhi 110062, India.
Mohd MujeebDepartment of Pharmacognosy and Phytochemistry, SPER, Jamia Hamdard, New Delhi 110062, India.
Tanveer NavedAmity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh 201301, India.
Mohammad Rashid KhanDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Khaled AlhosainiDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Yasser A AlqarniDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Rani RahatDepartment of Periodontics, College of Dentistry, University of Illinois Chicago, Chicago, IL 60612, USA.
Perwez AlamDepartment of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Swati MadanAmity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh 201301, India.
King Saud University · SAAmity University · INJamia Hamdard · INUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most prevalent lifestyle diseases, diabetes mellitus (DM) is brought on by an endocrine issue. DM is frequently accompanied by hyperglycemia, a disease that typically results in an excess of free radicals that stress tissues. The medical community is currently concentrating on creating therapeutic medications with roots in nature to lessen the damage associated with hyperglycemia.

Indexed as

Box-behnken designCLSMDiabetesNanoformulationNiosome

Identifiers

PMID37766819
PMCPMC10520944
OpenAlexW4386701105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.